Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 30

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 30
---
 related agreements and approve the Divestiture; and (iv) directed that the Divestiture Agreement and related agreements and the
Divestiture be submitted to a vote of Aadi’s stockholders.

Aadi’s board of directors unanimously recommends that you vote (i) “FOR” the Divestiture Proposal and (ii) “FOR” the Adjournment Proposal

Certain factors considered by our board of directors in making such
unanimous determination and approval are described in the section entitled “The Divestiture—Reasons for the Divestiture and Recommendation of theAadiBoard of Directors.”

Opinion of Aadi’s Financial Advisor (see page [●])

Aadi retained Leerink Partners as its financial advisor in connection with the Divestiture and the other transactions contemplated by the Divestiture
Agreement. On December 19, 2024, Leerink Partners rendered to Aadi’s board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion to Aadi’s board of directors dated December 19, 2024, that, as
of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, the consideration proposed to be paid to Aadi pursuant to the
terms of the Divestiture Agreement was fair, from a financial point of view, to Aadi.

The full text of the written opinion of Leerink Partners, dated
December 19, 2024, which describes the assumptions made and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, is attached as to this proxy statement and is
incorporated herein by reference. Leerink Partners’ financial advisory services and opinion were provided for the information and assistance of Aadi’s board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of the Aadi board of directors’ consideration of the Divestiture and the opinion of Leerink Partners addressed only the fairness, from a financial point of view, as of the date thereof, to Aadi of the consideration proposed to be paid to Aadi pursuant to the terms of the Divestiture Agreement. The opinion of Leerink Partners did not address any other term or aspect of the Divestiture Agreement or the Divestiture and does not constitute a recommendation to any stockholder of Aadi as to whether or how such holder should vote with respect to the Divestiture or otherwise act